 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
Date |
Open |
High |
Low |
Close |
Volume |
06/27/2022 |
$45.23 |
$45.28 |
$42.52 |
$44.10 |
1.63M | 06/28/2022 |
$44.00 |
$44.91 |
$40.95 |
$41.11 |
2.26M | 06/29/2022 |
$40.83 |
$41.36 |
$39.61 |
$40.58 |
1.19M | 06/30/2022 |
$40.13 |
$40.42 |
$38.53 |
$39.39 |
1.75M | 07/01/2022 |
$39.81 |
$41.51 |
$39.61 |
$41.13 |
1.46M |
 |
Exact Sciences is a cancer screening and diagnostics company. Co.'s primary screening product, the Cologuard® test, is a non-invasive stool-based DNA screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. Co.'s portfolio of Oncotype tests include: Oncotype DX gene expression tests for breast, prostate and colon cancers; Oncotype DX AR-V7 Nucleus Detect® test, a liquid-based test for advanced stage prostate cancer; and Oncotype MAP Pan-Cancer Tissue test (oncomap test), a test delivering tumor profiling to aid therapy selection for patients with metastatic, refractory or recurrent cancer. | |
 |

EXACT Sciences (EXAS) has the following price history information. Looking back at EXAS historical stock prices for the last five trading days, on June 27, 2022, EXAS opened at $45.23, traded as high as $45.28 and as low as $42.52, and closed at $44.10. Trading volume was a total of 1.63M shares. On June 28, 2022, EXAS opened at $44.00, traded as high as $44.91 and as low as $40.95, and closed at $41.11. Trading volume was a total of 2.26M shares. On June 29, 2022, EXAS opened at $40.83, traded as high as $41.36 and as low as $39.61, and closed at $40.58. Trading volume was a total of 1.19M shares. On June 30, 2022, EXAS opened at $40.13, traded as high as $40.42 and as low as $38.53, and closed at $39.39. Trading volume was a total of 1.75M shares. On July 01, 2022, EXAS opened at $39.81, traded as high as $41.51 and as low as $39.61, and closed at $41.13. Trading volume was a total of 1.46M shares.
EXAS Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into EXACT Sciences shares, starting with a $10,000 purchase of EXAS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
07/03/2012 |
|
End date: |
07/01/2022 |
|
Start price/share: |
$11.18 |
|
End price/share: |
$41.13 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
267.89% |
|
Average Annual Total Return: |
13.91% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$36,780.58 |
|
Years: |
10.00 |
|
|
 |
Date |
Close |
06/27/2022 | $44.10 | 06/28/2022 | $41.11 | 06/29/2022 | $40.58 | 06/30/2022 | $39.39 | 07/01/2022 | $41.13 |
|
 |